These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 20080392)
1. Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study. Bresee LC; Majumdar SR; Patten SB; Johnson JA Schizophr Res; 2010 Mar; 117(1):75-82. PubMed ID: 20080392 [TBL] [Abstract][Full Text] [Related]
2. Diabetes, cardiovascular disease, and health care use in people with and without schizophrenia. Bresee LC; Majumdar SR; Patten SB; Johnson JA Eur Psychiatry; 2011; 26(5):327-32. PubMed ID: 20634043 [TBL] [Abstract][Full Text] [Related]
3. Utilization of general and specialized cardiac care by people with schizophrenia. Bresee LC; Majumdar SR; Patten SB; Johnson JA Psychiatr Serv; 2012 Mar; 63(3):237-42. PubMed ID: 22307876 [TBL] [Abstract][Full Text] [Related]
4. Exploring the Distribution of Prescription for Sulfonylureas in Patients with Type 2 Diabetes According to Cardiovascular Risk Factors Within a Canadian Primary Care Setting. Farahani P; Khan S; Oatway M; Dziarmaga A J Popul Ther Clin Pharmacol; 2015; 22(3):e228-36. PubMed ID: 26567749 [TBL] [Abstract][Full Text] [Related]
5. Risk of Major Cardiovascular Events in People with Down Syndrome. Sobey CG; Judkins CP; Sundararajan V; Phan TG; Drummond GR; Srikanth VK PLoS One; 2015; 10(9):e0137093. PubMed ID: 26421620 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study. Dalleywater W; Powell HA; Hubbard RB; Navaratnam V Chest; 2015 Jan; 147(1):150-156. PubMed ID: 25121965 [TBL] [Abstract][Full Text] [Related]
7. Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Szabo SM; Levy AR; Rao SR; Kirbach SE; Lacaille D; Cifaldi M; Maksymowych WP Arthritis Rheum; 2011 Nov; 63(11):3294-304. PubMed ID: 21834064 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. Curkendall SM; Mo J; Glasser DB; Rose Stang M; Jones JK J Clin Psychiatry; 2004 May; 65(5):715-20. PubMed ID: 15163261 [TBL] [Abstract][Full Text] [Related]
9. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
10. Schizophrenia and the incidence of cardiovascular morbidity: a population-based longitudinal study in Ontario, Canada. Callaghan RC; Boire MD; Lazo RG; McKenzie K; Cohn T Schizophr Res; 2009 Dec; 115(2-3):325-32. PubMed ID: 19793638 [TBL] [Abstract][Full Text] [Related]
11. Standard cardiovascular disease risk algorithms underestimate the risk of cardiovascular disease in schizophrenia: evidence from a national primary care database. McLean G; Martin JL; Martin DJ; Guthrie B; Mercer SW; Smith DJ Schizophr Res; 2014 Oct; 159(1):176-81. PubMed ID: 25128454 [TBL] [Abstract][Full Text] [Related]
12. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women. Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease rates, outcomes, and quality of care in Ontario Métis: a population-based cohort study. Atzema CL; Khan S; Lu H; Allard YE; Russell SJ; Gravelle MR; Klein-Geltink J; Austin PC PLoS One; 2015; 10(3):e0121779. PubMed ID: 25793978 [TBL] [Abstract][Full Text] [Related]
14. Peripheral endothelial dysfunction as a marker of cardiovascular risk in physically healthy patients with schizophrenia and related psychoses: a matched case control study. Protopopova D; Masopust J; Malý R; Valis M; Dostalova G; Ranna K; Bažant J Neuro Endocrinol Lett; 2014; 35(6):503-9. PubMed ID: 25433846 [TBL] [Abstract][Full Text] [Related]
15. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Goto S; Bhatt DL; Röther J; Alberts M; Hill MD; Ikeda Y; Uchiyama S; D'Agostino R; Ohman EM; Liau CS; Hirsch AT; Mas JL; Wilson PW; Corbalán R; Aichner F; Steg PG; Am Heart J; 2008 Nov; 156(5):855-63, 863.e2. PubMed ID: 19061698 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of diabetes in patients with schizophrenia in Taiwan: a population-based National Health Insurance study. Chien IC; Hsu JH; Lin CH; Bih SH; Chou YJ; Chou P Schizophr Res; 2009 Jun; 111(1-3):17-22. PubMed ID: 19401264 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome. Esteghamati A; Abbasi M; Nakhjavani M; Yousefizadeh A; Basa AP; Afshar H Cardiovasc Diabetol; 2006 Jul; 5():15. PubMed ID: 16842631 [TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656 [TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295 [TBL] [Abstract][Full Text] [Related]
20. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study. Whitfield MD; Gillett M; Holmes M; Ogden E Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]